Effects of β2-agonist administration and exercise on contractile activation of skeletal muscle fibers

Journal of Applied Physiology

Volumn 81, Issue 4, 1996, Pages 1610-1618

  Lynch, Gordon S ^a,b   Hayes, Alan ^a   Campbell, Siun P ^a   Williams, David A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

fiber types; mouse; muscle contraction; skinned fibers

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; EXTENSOR DIGITORUM LONGUS MUSCLE; FAST MUSCLE; HISTOCHEMISTRY; MEMBRANE PERMEABILITY; MOUSE; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SKELETAL MUSCLE;

EID: 0029797113     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1996.81.4.1610     Document Type: Article

References (44)

1. Agbenyega, E. T., and A. C. Wareham. Effect of clenbuterol on normal and denervated muscle growth and contractility. Muscle Nerve 13: 199-203, 1990.
2. Brandt, P. W., M. S. Diamond, J. S. Rutchik, and F. H. Schachat. Co-operative interactions between troponin-tropomyosin units extend the length of the thin filament in skeletal muscle. J. Mol Biol. 195: 885-896, 1987.
3. Cairns, S. P., and A. F. Dulhunty. β-Adrenergic potentiation of E-C coupling increases force in rat skeletal muscle. Muscle Nerve 16: 1317-1325, 1993.
4. Carter, W. J., A. Q. Dang, F. H. Faas, and M. E. Lynch. Effects of clenbuterol on skeletal muscle mass, body composition, and recovery from surgical stress in senescent rats. Metabolism. 40: 855-860, 1991.
5. 2-adrenoceptor activation. Am. J. Physiol. 263 (Endocrinol. Metab. 26): E50-E56, 1992.
6. Delbeke, F. T., N. Desmet, and M. Debackere. The abuse of doping agents in competing bodybuilders in Flanders (1988-1993). Int. J. Sports Med. 16: 66-70, 1995.
7. Duncan, N. D., G. S. Lynch, D. L. Jones, and D. A. Williams. The effects of clenbuterol on skeletal and cardiac muscle of rats when combined with low intensity endurance exercise (Abstract). Proc. Aust. Physiol. Pharmacol. Soc. 25: 21P, 1994.
8. Duncan, N. D., G. S. Lynch, and D. A. Williams. Skeletal muscle adaptations resulting from moderate sprint training and clenbuterol administration (Abstract.). Proc. Aust. Physiol. Pharmacol. Soc. 25: 46P, 1994.
9. Elzinga, G., G. J. M. Stienen, and M. G. A. Wilson. Isometric force production before and after chemical skining in isolated muscle fibres of the frog Rana temporaria. J. Physiol. Land. 410: 171-185, 1989.
10. Fink, R. H. A., D. G. Stephenson, and D. A. Williams. Calcium and strontium activation of single skinned muscle fibres of normal and dystrophic mice. J. Physiol. Land. 373: 513-525, 1986.
11. Hayes, A., G. S. Lynch, and D. A. Williams. The effects of endurance exercise on dystrophic mdx mice. I. Contractile and histochemical properties of intact muscles. Proc. R. Soc. Lond. Ser. B Biol. Sci. 253: 19-25, 1993.
12. Hayes, A., and D. A. Williams. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. Clin. Exp. Pharmacol. Physiol 21: 757-765, 1994.
13. Herzig, J. W., G. Köhler, G. Pfitzcr, J. C. Rücgg, and G. Wölffle. Cyclic AMP inhibits contractility of detergent treated glycerol extracted cardiac muscle. Pfluegers Arch. 391: 208-212, 1981.
14. Karpati, G., S. Carpenter, and S. Prescott. Small caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11: 795-803, 1988.
15. 2 receptor agonist therapy. In: The Role of Beta Receptor Agonist Therapy in Asthma Mortality, edited by R. Beasley and N. E. Pearce. London: CRC, 1993, p. 163-199.
16. Kim, Y. S., and R. D. Sainz. β-Adrenergic agonists and hypertrophy of skeletal muscles. Life Sci. 50: 397-407, 1992.
17. Levitzki, A. β-Adrenergic receptors and their mode of coupling to adenylate cyclase. Physiol. Rev. 66: 819-854, 1986.
18. Lynch, G. S., A. Hayes, M. H. C. Lam, and D. A. Williams. The effects of endurance exercise on dystrophic mdx mice II. Contractile properties of skinned muscle fibres. Proc. Royal Soc. Lond. Ser. B Biol. Sci 253: 27-33, 1993.
19. Lynch, G. S., D. G. Stephenson, and D. A. Williams. Endurance exercise effects on the contractile properties of single skinned skeletal muscle fibres of young rats. Pfluegers Arch. 418: 161-167, 1991.
20. Lynch, G. S., and D. A. Williams. The effect of exercise on the contractile properties of fast- and slow-twitch skeletal muscle fibres from the adult rat. Acta Physiol. Scand. 150: 141-150, 1994.
21. Maltin, C. A., M. I. Delday, and P. J. Reeds. The effect of a growth promoting drug, clenbuterol, on fiber frequency and area in hind limb muscles from young male rats. Biosci. Rep. 6: 293-299 1986
22. Maltin, C. A., M. I. Delday, J. S. Watson, D. Heys, I. M. Nevison, I. K. Ritchie, and P. H. Gibson. Clenbuterol, a β-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin. Sci. Lond. 84: 651-654, 1993.
23. Maltin, C. A., S. M. Hay, M. I. Delday, F. G. Smith, G. E. Lobley, and P. J. Reeds. Clenbuterol, a beta-agonist, induces growth in innervated and denervated rat soleus muscle via apparently different mechanisms. Biosci. Rep. 7: 525-532, 1987.
24. McElligott, M. A., A. Barreto, Jr., and L. Y. Chaung. Effect of continuous and intermittent clenbuterol feeding on rat growth rate and muscle. Comp. Biochem. Physiol. C Comp. Pharmacol. 92C: 135-138, 1989.
25. Mersmann, H. J. Potential mechanisms for reapportioning of growth by β-adrenergic agonists. In: Animal Growth Regulation, edited by D. R. Campion, G. J. Hausman, and R. J. Martin. New York: Plenum, 1989, p. 337-357.
26. Moisescu, D. G., and R. Thieleczek. Calcium and strontium concentration changes within skinned muscle preparations following a change in the external bathing solution. J. Physiol. Lond. 275: 241-262, 1978.
27. 2-adrenoceptor agonist salmeterol are dependent on route of administration. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E475-E484, 1994.
28. Ogilvie, R. W., and D. L. Feeback. A metachromatic dye-ATPase method for the simultaneous identification of skeletal muscle fiber types I, IIA, IIB and IIC. Stain Technol. 65: 231-241, 1990.
29. Palmer, R. M., M. I. Delday, D. N. McMillan, B. S. Noble, P. Bain, and C. A. Maltin. Effects of the cyclo-oxygenase inhibitor, fenbufen, on clenbuterol-induced hypertrophy of cardiac and skeletal muscle of rats. Br. J. Pharmacol. 101: 835-838, 1990.
30. 2+ sensitivity of mammalian skinned cardiac and skeletal muscle fibres. J. Physiol. Lond. 480: 45-60, 1994.
31. Prather, I. D., D. E. Brown, P. North and J. R. Wilson. Clenbuterol: a substitute for anabolic steroids. Med. Sci. Sports Exercise 27: 1118-1121, 1995.
32. Reeds, P. J., S. M. Hay, P. M. Dorward, and R. M. Palmer. Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis. Br. J. Nutr. 56: 249-258, 1986.
33. Roberts, P., and J. K. McGeachie. The effects of clenbuterol on satellite cell activation and the regeneration of skeletal muscle: an autoradiographic and morphonietric study of whole muscle transplants in mice. J. Anat. 180: 57-65, 1994.
34. Rothwell, N. J., and M. J. Stock. Modification of body composition by clenbuterol in normal and dystrophic (mdx) mice. Biosci. Rep. 5: 755-760, 1985.
35. Stephenson, D. G., and D. A. Williams. Calcium-activated force responses in fast- and slow-twitch skinned muscle fibres of the rat at different temperatures. J. Physiol. Land. 317: 281-302, 1981.
36. Stephenson, D. G., and D. A. Williams. Effects of sarcomere length on the force-pCa relation in fast- and slow-twitch skinned muscle fibres from the rat. J. Physiol. Land. 333: 637-653, 1982.
37. Talmadge, R. J., and R. R. Roy. Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J. Appl. Phvsiol. 75: 2337-2340, 1993.
38. Torgan, C. E., G. J. Etgen, Jr., H. Y. Kang, and J. L. Ivy. Fiber type-specific effects of clenbuterol and exercise training on insulin-resistant muscle. J. Appl. Physiol. 79: 163-167, 1995.
39. Webster, C., L. Silberstein, A. P. Hays, and H. M. Blau. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52: 503-513, 1988.
40. Williams, D. A., S. I. Head, G. S. Lynch, and D. G. Stephenson. Contractile properties of skinned muscle fibres from normal and dystrophic (mdx) mice. J. Physiol. Lond. 460: 51-67, 1993.
41. Yang, Y. T., and M. A, McElligott. Multiple actions of β-adrenergic agonists on skeletal muscle and adipose tissue. Biochem. J. 261: 1-10, 1989.
42. 2-receptor agonist. Am. J. Physiol. 254 (Endocrinol Metab. 17): E726-E732, 1988.
43. 2-agonist, retards atrophy in denervated muscles. Am. J. Physiol 252 (Endocrinol. Metab. 15): E152-E155, 1987.
44. 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle. Am. J. Physiol. 267 (Cell Physiol. 36): C865-C868, 1994.